Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers

Clinical trial NCT05663372 · COMPLETED

Trial details

NCT number: NCT05663372
Sponsor: Darnitsa Pharmaceutical Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Healthy Subjects

Start date: 2021-12-07
Primary completion: 2021-12-28
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.